Second Chance for Moms Act

# Second Chance for Moms Act - Summary **What the Bill Would Do** The Second Chance for Moms Act would require new labeling requirements for mifepristone (the "abortion pill"), specifically mandating that labels include information about the hormone progesterone. The bill would also establish a telephone hotline related to this information. Mifepristone is a FDA-approved medication used to end pregnancies up to 10 weeks gestation when combined with another drug called misoprostol. **Who It Affects and Current Status** This bill would primarily affect women considering medication abortion, healthcare providers who prescribe mifepristone, and pharmaceutical companies that manufacture the drug.

The bill is currently in committee, meaning it has been introduced but has not yet been debated or voted on by the full House of Representatives. The bill was sponsored by Representative Mary E. Miller (R-IL).